Institute of Haematology and Blood Transfusion

Recent papers from Institute of Haematology and Blood Transfusion

1. Persistent neutrophil maturation deficits associate with cognitive impairment in individuals with post-acute sequelae of COVID-19Frontiers in Immunology · 2026
2. Misfolded plasma protein signature in carotid artery dissectionClinical Proteomics · 2026
3. Generation of four human induced pluripotent stem cell lines from dermal fibroblasts of healthy female donorStem Cell Research · 2026
4. Choice of a different donor reduces relapse risk after second allogeneic SCT for MDSBlood · 2026
5. FAIR but Restricted: Stewardship of Genomic and Sensitive Data in Clinical Research2026
6. Real-world effectiveness of pegcetacoplan in individuals with paroxysmal nocturnal haemoglobinuria and suboptimal response to C5 inhibitorsTherapeutic Advances in Hematology · 2026
7. Metabolomic and Proteomic Profiling of Vaso-Occlusive Crises in Sickle Cell Disease: Current Evidence and Future PerspectivesHemoglobin · 2026
8. Nucleolin Alterations and ROS Production Associate With Sensitivity of AML Cells to VenetoclaxThe FASEB Journal · 2026
9. Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working partyBone Marrow Transplantation · 2026
10. Blood donation trends in Zhejiang Province, 2017–2025: an ecological study before, during, and after COVID-19Frontiers in Public Health · 2026
11. The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic SyndromeseJHaem · 2026
12. Hepatitis B virus infection with high HBsAg and undetectable DNA levels in untreated blood donors: Viral mechanisms and transfusion safety implicationsTransfusion · 2026
13. TLR-mediated calcium signaling regulates killing capacity of expanded NK cells: challenges for potential AML immunotherapyJournal of Leukocyte Biology · 2026
14. Longitudinal assessment of sNfL and sGFAP in severe NMOSD treated with allogeneic stem cell transplantationFrontiers in Immunology · 2026
15. Variant-specific SF3B1 mutations drive distinct splicing and mitochondrial dysfunction in myelodysplastic neoplasmsHuman Genomics · 2026
16. Salivary Gene Expression Changes after Total Body Irradiation in Leukemia Patients: Toward Non-invasive BiodosimetryRadiation Research · 2026
17. Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial2023
18. Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry‐Based Study on Behalf of the Chronic Malignancies Working of the EBMTAmerican Journal of Hematology · 2026
19. Real-World Outcomes of Mantle Cell Lymphoma Treated With Rituximab-Based Chemotherapy Regimens: Experience From a Single Institution in VietnamCancer Control · 2026
20. Regulating algorithmic tools in reproductive health: ethical and legal challengesFrontiers in Reproductive Health · 2026